Wordt geladen...
Ciclopirox Olamine inhibits mTORC1 signaling by activation of AMPK
Ciclopirox olamine (CPX), an off-patent antifungal agent, has recently been identified as a potential anticancer agent. The mammalian target of rapamycin (mTOR) is a central controller of cell growth, proliferation and survival. Little is known about whether and how CPX executes its anticancer actio...
Bewaard in:
| Gepubliceerd in: | Biochem Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5003681/ https://ncbi.nlm.nih.gov/pubmed/27396756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2016.07.005 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|